Felix E. De Jongh
Rotterdam, ZH, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 23 publications
Implementation of model-informed precision dosing for tamoxifen therapy in patients with breast cancer: A prospective intervention study.
Journal: Breast (Edinburgh, Scotland)
Published: August 10, 2024
A cost-consequence model of using the 21-gene assay to identify patients with early-stage node-positive breast cancer who benefit from adjuvant chemotherapy in the Netherlands.
Journal: Journal of medical economics
Published: March 04, 2024
Cost and Clinical Benefits Associated with Oncotype DX® Test in Patients with Early-Stage HR+/HER2- Node-Negative Breast Cancer in the Netherlands.
Journal: International journal of breast cancer
Published: March 16, 2022
Prospective Evaluation of a Circulating Tumor Cell Sensitivity Profile to Predict Response to Cisplatin Chemotherapy in Metastatic Breast Cancer Patients.
Journal: Frontiers in oncology
Published: April 19, 2021
Loss of skeletal muscle index and survival in patients with metastatic colorectal cancer: Secondary analysis of the phase 3 CAIRO3 trial.
Journal: Cancer medicine
Published: March 05, 2019
Skeletal muscle mass loss and dose-limiting toxicities in metastatic colorectal cancer patients.
Journal: Journal of cachexia, sarcopenia and muscle
Published: October 17, 2018
Androgen receptor expression in circulating tumor cells of patients with metastatic breast cancer.
Journal: International journal of cancer
Published: September 24, 2018
An Optimized Workflow to Evaluate Estrogen Receptor Gene Mutations in Small Amounts of Cell-Free DNA.
Journal: The Journal of molecular diagnostics : JMD
Published: June 05, 2018
Maintenance treatment with capecitabine and bevacizumab versus observation in metastatic colorectal cancer: updated results and molecular subgroup analyses of the phase 3 CAIRO3 study.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: September 16, 2017
Prognostic Impact of HER2 and ER Status of Circulating Tumor Cells in Metastatic Breast Cancer Patients with a HER2-Negative Primary Tumor.
Journal: Neoplasia (New York, N.Y.)
Published: August 04, 2016
Hypophosphataemia due to FGF-23 producing B cell non-Hodgkin's lymphoma.
Journal: BMJ case reports
Published: April 28, 2016
Last Updated: 09/26/2026